Figures

Figure 2.1 Population distribution of NI wards and RoI EDs

Figure 3.1 Age distribution of non-melanoma skin cancer cases in Ireland, 1995-2007, by sex

Figure 3.2 Adjusted relative risks (with 95% confidence intervals) of non-melanoma skin cancer by socio-economic characteristics of geographic area of residence: males

Figure 3.3 Adjusted relative risks (with 95% confidence intervals) of non-melanoma skin cancer by socio-economic characteristics of geographic area of residence: females

Figure 4.1 Age distribution of female breast cancer cases in Ireland, 1995-2007

Figure 4.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: female breast cancer

Figure 4.3 Adjusted relative risks (with 95% confidence intervals) of breast cancer by socio-economic characteristics of geographic area of residence: females

Figure 5.1 Age distribution of colorectal cases in Ireland, 1995-2007, by sex

Figure 5.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: colorectal cancer

Figure 5.3 Adjusted relative risks (with 95% confidence intervals) of colorectal cancer by socio-economic characteristics of geographic area of residence: males

Figure 5.4 Adjusted relative risks (with 95% confidence intervals) of colorectal cancer by socio-economic characteristics of geographic area of residence: females

Figure 6.1 Age distribution of lung cancer cases in Ireland, 1995-2007, by sex

Figure 6.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: lung cancer

Figure 6.3 Adjusted relative risks (with 95% confidence intervals) of lung cancer by socio-economic characteristics of geographic area of residence: males

Figure 6.4 Adjusted relative risks (with 95% confidence intervals) of lung cancer by socio-economic characteristics of geographic area of residence: females

Figure 7.1 Age distribution of prostate cancer cases in Ireland, 1995-2007

Figure 7.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: prostate cancer

Figure 7.3 Adjusted relative risks (with 95% confidence intervals) of prostate cancer by socio-economic characteristics of geographic area of residence

Figure 8.1 Age distribution of non-Hodgkin's lymphoma cases in Ireland, 1995-2007, by sex

Figure 8.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: non-Hodgkin's lymphoma

Figure 8.3 Adjusted relative risks (with 95% confidence intervals) of non-Hodgkin's lymphoma by socio-economic characteristics of geographic area of residence: males

Figure 8.4 Adjusted relative risks (with 95% confidence intervals) of non-Hodgkin's lymphoma by socio-economic characteristics of geographic area of residence: females

Figure 9.1 Age distribution of stomach cancer cases in Ireland, 1995-2007, by sex

Figure 9.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: stomach cancer

Figure 9.3 Adjusted relative risks (with 95% confidence intervals) of stomach cancer by socio-economic characteristics of geographic area of residence: males

Figure 9.4 Adjusted relative risks (with 95% confidence intervals) of stomach cancer by socio-economic characteristics of geographic area of residence: females

Figure 10.1 Age distribution of cases of melanoma of the skin in Ireland, 1995-2007, by sex

Figure 10.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: malignant melanoma of skin

Figure 10.3 Adjusted relative risks (with 95% confidence intervals) of melanoma of the skin by socio-economic characteristics of geographic area of residence: males

Figure 10.4 Adjusted relative risks (with 95% confidence intervals) of melanoma of the skin by socio-economic characteristics of geographic area of residence: females

Figure 11.1 Age distribution of bladder cancer cases in Ireland, 1995-2007, by sex

Figure 11.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: bladder cancer

Figure 11.3 Adjusted relative risks (with 95% confidence intervals) of bladder cancer by socio-economic characteristics of geographic area of residence: males

Figure 11.4 Adjusted relative risks (with 95% confidence intervals) of bladder cancer by socio-economic characteristics of geographic area of residence: females

Figure 12.1 Age distribution of head and neck cancer cases in Ireland, 1995-2007, by sex

Figure 12.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: head and neck cancer

Figure 12.3 Adjusted relative risks (with 95% confidence intervals) of head and neck cancer by socio-economic characteristics of geographic area of residence: males

Figure 12.4 Adjusted relative risks (with 95% confidence intervals) of head and neck cancer by socio-economic characteristics of geographic area of residence: females

Figure 13.1 Age distribution of leukaemia cases in Ireland, 1995-2007, by sex

Figure 13.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: leukaemia

Figure 13.3 Adjusted relative risks (with 95% confidence intervals) of leukaemia by socio-economic characteristics of geographic area of residence: males

Figure 13.4 Adjusted relative risks (with 95% confidence intervals) of leukaemia by socio-economic characteristics of geographic area of residence: females

Figure 14.1 Age distribution of pancreatic cancer cases in Ireland, 1995-2007, by sex

Figure 14.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: pancreatic cancer

Figure 14.3 Adjusted relative risks (with 95% confidence intervals) of pancreatic cancer by socio-economic characteristics of geographic area of residence: males

Figure 14.4 Adjusted relative risks (with 95% confidence intervals) of pancreatic cancer by socio-economic characteristics of geographic area of residence: females

Figure 15.1 Age distribution of kidney cancer cases in Ireland, 1995-2007, by sex

Figure 15.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: kidney cancer

Figure 15.3 Adjusted relative risks (with 95% confidence intervals) of kidney cancer by socio-economic characteristics of geographic area of residence: males

Figure 15.4 Adjusted relative risks (with 95% confidence intervals) of kidney cancer by socio-economic characteristics of geographic area of residence: females

Figure 16.1 Age distribution of oesophageal cancer cases in Ireland, 1995-2007, by sex

Figure 16.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: oesophageal cancer

Figure 16.3 Adjusted relative risks (with 95% confidence intervals) of oesophageal cancer by socio-economic characteristics of geographic area of residence: males

Figure 16.4 Adjusted relative risks (with 95% confidence intervals) of oesophageal cancer by socio-economic characteristics of geographic area of residence: females

Figure 17.1 Age distribution of ovarian cancer cases in Ireland, 1995-2007

Figure 17.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incid*ence rate for RoI and NI: ovarian cancer

Figure 17.3 Adjusted relative risks (with 95% confidence intervals) of ovarian cancer by socio-economic characteristics of geographic area of residence

Figure 18.1 Age distribution of brain and other central nervous system cancer cases in Ireland, 1995-2007, by sex

Figure 18.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: brain and other central nervous system cancers

Figure 18.3 Adjusted relative risks (with 95% confidence intervals) of brain and other central nervous system cancer by socio-economic characteristics of geographic area of residence: males

Figure 18.4 Adjusted relative risks (with 95% confidence intervals) of brain and other central nervous system cancer by socio-economic characteristics of geographic area of residence: females

Figure 19.1 Age distribution of cases of uterine cancer in Ireland, 1995-2007

Figure 19.2 Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: uterine cancer

Figure 19.3 Adjusted relative risks (with 95% confidence intervals) of uterine cancer by socio-economic characteristics of geographic area of residence

Figure 20.1 Age distribution of cases of cervical cancer in Ireland, 1995-2007

Figure 20.2: Estimated incidence rate per 100,000 in 2008 for selected developed countries compared to 2005-2007 incidence rate for RoI and NI: cervical cancer

Figure 20.3 Adjusted relative risks (with 95% confidence intervals) of cancer of the cervix uteri by socio-economic characteristics of geographic area of residence

Figure 21.1 Smoking prevalence in Health and Social Services Boards and HSE regions, 2009-2010

Figure 21.2 Percentage of Irish population who were overweight or obese, by area of residence, 2005-2006

Figure 21.3 Trends in female breast cancer incidence for RoI and NI 1994-2009 (European age-standardised incidence rates ± 95% confidence limits)

Maps

Map 2.1 Counties and district councils

Map 2.2 Locations

Maps 2.3-2.6 Ward/ED characteristics

Map 2.7 Colorectal cancer, crude standardised incidence ratios: males, 1995-2007

Map 2.8 Colorectal cancer, smoothed relative risks: males, 1995-2007

Map 3.1 Non-melanoma skin cancer, smoothed relative risks: both sexes

Map 3.2 Non melanoma skin cancer, smoothed relative risks: males

Map 3.3 Non melanoma skin cancer, smoothed relative risks: females

Map 4.1 Breast cancer, smoothed relative risks: females 1995-2007

Map 4.2 Breast cancer, smoothed relative risks: females 1995-2001

Map 4.3 Breast cancer, smoothed relative risks: females 2002-2007

Map 5.1 Colorectal cancer, smoothed relative risks: both sexes

Map 5.3 Colorectal cancer, smoothed relative risks: females

Map 6.1 Lung cancer, smoothed relative risks: both sexes

Map 6.2 Lung cancer, smoothed relative risks: males

Map 6.3 Lung cancer smoothed relative risks: females

Map 7.1 Prostate cancer, smoothed relative risks 1995-2007

Map 7.2 Prostate cancer, smoothed relative risks: 1995-2001

Map 7.3 Prostate cancer, smoothed relative risks: 2002-2007

Map 8.1 Non-Hodgkin's lymphoma, smoothed relative risks: both sexes

Map 8.2 Non-Hodgkin's lymphoma, smoothed relative risks: males

Map 8.3 Non-Hodgkin's lymphoma, smoothed relative risks: females

Map 9.1 Stomach cancer, smoothed relative risks: both sexes

Map 9.2 Stomach cancer, smoothed relative risks: males

Map 9.3 Stomach cancer, smoothed relative risks: females

Map 10.1 Melanoma of the skin, smoothed relative risks: both sexes

Map 10.2 Melanoma of the skin, smoothed relative risks: males

Map 10.3 Melanoma of the skin, smoothed relative risks: females

Map 11.1 Bladder cancer, smoothed relative risks: both sexes

Map 11.2 Bladder cancer, smoothed relative risks: males

Map 11.3 Bladder cancer, smoothed relative risks: females

Map 12.1 Head and neck cancer, smoothed relative risks: both sexes

Map 12.2 Head and neck cancer, smoothed relative risks: males

Map 12.3 Head and neck cancer, smoothed relative risks: females

Map 13.1 Leukaemia, smoothed relative risks: both sexes

Map 13.2 Leukaemia, smoothed relative risks: males

Map 13.3 Leukaemia, smoothed relative risks: females

Map 14.1 Pancreatic cancer, smoothed relative risks: both sexes

Map 14.2 Pancreatic cancer, smoothed relative risks: males

Map 14.3 Pancreatic cancer, smoothed relative risks: females

Map 15.1 Kidney cancer, smoothed relative risks: both sexes

Map 15.2 Kidney cancer, smoothed relative risks: males

Map 15.3 Kidney cancer, smoothed relative risks: females

Map 16.1 Oesophageal cancer, smoothed relative risks: both sexes

Map 16.2 Oesophageal cancer, smoothed relative risks: males

Map 16.3 Oesophageal cancer, smoothed relative risks: females

Map 17.1 Ovarian cancer, smoothed relative risks

Map 18.1 Brain and other central nervous system cancer, smoothed relative risks: both sexes

Map 18.2 Brain and other central nervous system cancer, smoothed relative risks: males

Map 18.3 Brain and other central nervous system cancer, smoothed relative risks: females

Map 19.1 Cancer of the corpus uteri, smoothed relative risks

Map 20.1 Cancer of the cervix uteri, smoothed relative risks

Map 21.1 Relative risk of non-melanoma skin cancer (both sexes) and location of larger fishing ports

Map 21.2 Relative risk of non-melanoma skin cancer (both sexes ) and annual sunshine 1961-1990

Map 21.3 Average age of mother at first birth, RoI 1989-1998, NI 1997-1998

Map 21.4 Relative risk of melanoma 1994-2007 and annual sunshine hours 1961-1990

Tables

Table 2.1 Incident cancers diagnosed 1995-2007 included in this report: Republic of Ireland (RoI) and Northern Ireland (NI)

Table 2.2 Number and percentage of cases not assigned to an ED or ward, and of cases assigned to multiple EDs

Table 2.3 Population distribution of NI wards and RoI EDs

Table 2.4 Distribution of cancer cases and estimated average population in 1995-2007, and number of EDs and wards, by population density tertiles

Table 2.5 Population and number of areas (wards and EDs) included in each area-based socio-economic category

Table 2.6 Correlation coefficients (Spearman's rank) for ward/ED characteristics

Table 2.7 Mean and variance in the number of cancer cases diagnosed in each ward/ED: 1995-2007

Table 3.1 Summary information for non-melanoma skin cancer in Ireland, 1995-2007

Table 3.2 Risk factors for non-melanoma skin cancer, by direction of association and strength of evidence

Table 4.1 Summary information for breast cancer in Ireland, 1995-2007

Table 4.2 Risk factors for breast cancer, by direction of association and strength of evidence

Table 5.1 Summary information for colorectal cancer in Ireland, 1995-2007

Table 5.2 Risk factors for colorectal cancer, by direction of association and strength of evidence

Table 6.1 Summary information for lung cancer in Ireland, 1995-2007

Table 6.2 Risk factors for lung cancer, by direction of association and strength of evidence

Table 7.1 Summary information for prostate cancer in Ireland, 1995-2007

Table 7.2 Risk factors for prostate cancer, by direction of association and strength of evidence

Table 8.1 Summary information for non-Hodgkin's lymphoma in Ireland, 1995-2007

Table 8.2 Risk factors for non-Hodgkin's lymphoma, by direction of association and strength of evidence

Table 9.1 Summary information for stomach cancer in Ireland, 1995-2007

Table 9.2 Risk factors for stomach cancer, by direction of association and strength of evidence

Table 10.1 Summary information for melanoma of the skin in Ireland, 1995-2007

Table 10.2 Risk factors for melanoma of the skin, by direction of association and strength of evidence

Table 11.1 Summary information for bladder cancer in Ireland, 1995-2007

Table 11.2 Risk factors for bladder cancer, by direction of association and strength of evidence

Table 12.1 Summary information for head and neck cancer in Ireland, 1995-2007

Table 12.2 Risk factors for head and neck cancer, by direction of association and strength of evidence

Table 13.1 Summary information for leukaemia in Ireland, 1995-2007

Table 13.2 Risk factors for leukaemia, by direction of association and strength of evidence

Table 14.1 Summary information for pancreatic cancer in Ireland, 1995-2007

Table 14.2 Risk factors for pancreatic cancer, by direction of association and strength of evidence

Table 15.1 Summary information for kidney cancer in Ireland, 1995-2007

Table 15.2 Risk factors for kidney cancer, by direction of association and strength of evidence

Table 16.1 Summary information for oesophageal cancer in Ireland, 1995-2007

Table 16.2 Risk factors for oesophageal cancer, by direction of association and strength of evidence

Table 17.1 Summary information for ovarian cancer in Ireland, 1995-2007

Table 17.2 Risk factors for ovarian cancer, by direction of association and strength of evidence

Table 18.1 Summary information for brain and other central nervous system cancer in Ireland, 1995-2007

Table 18.2 Risk factors for brain and other central nervous system cancer, by direction of association and strength of evidence

Table 19.1 Summary information for uterine cancer in Ireland, 1995-2007

Table 19.2 Risk factors for uterine cancer, by direction of association and strength of evidence

Table 20.1 Summary information for cervical cancer in Ireland, 1995-2007

Table 20.2 Risk factors for cervical cancer, by direction of association and strength of evidence

Table 21.1 Percentage of male population in Ireland employed in agriculture, forestry and fishing, 1981

Table A2.1 "Confidential" electoral divisions which were merged for census purposes, RoI

Table A2.2 Urban areas with population splits altered between 1996 and 2002 censuses

Table A2.3 Urban areas surrounded by a single ED (rural part)

Table A2.4 Drogheda, Dundalk and Wexford-Population splits not available for 1996 census and altered in 2002

Table A2.5 Islands and headlands joined artificially to mainland EDs or wards

Table A3.1 Summary statistics for each cancer site mapped: numbers of cases per ED or ward, ranges of SIRs and smoothed RRs for 1995-2007

Table A4.1 Regions referred to in the atlas